Trial reportIndian journal of ophthalmology2026
Comparison of accelerated corneal collagen cross-linking under normal and increased oxygen concentrations: A pilot study.
Trial report in Indian journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the role of local oxygen supplementation in accelerated collagen cross-linking (CXL) in human subjects.
methodPatients with progressive keratoconus were enrolled and randomized to undergo accelerated CXL in either local oxygen supplementation (Group 1, Cases, n = 10) or room-air oxygen (Group 2, Controls, n = 10). Baseline uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refractive spherical equivalent (MRSE), corneal tomographic parameters, corneal biomechanics, and wavefront analysis were documented. Patients were followed up at 1 week, 1 month, 3 months, and 6 months.
resultsTwenty eyes of 20 patients (Group 1, Cases, n = 10; Group 2, Controls, n = 10) were enrolled. At 6 months, both groups exhibited significant flattening of steepest keratometry, increased corneal optical densitometry, and reduced thinnest pachymetry. No eye had keratoconus progression in either group. There was no significant change in UDVA, CDVA, and MRSE in both groups. No intergroup significant differences were found in UDVA, CDVA, MRSE, steepest keratometry (Kmax), or corneal astigmatism. Demarcation line depth was comparable between groups at 6 months.
conclusionAccelerated CXL is a useful modality to manage progressive keratoconus. However, in short term, local oxygen supplementation does not seem to have any additional benefit over room-air oxygen. Larger studies with longer follow-up period are required to further investigate the same.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.